Arbutus Biopharma
Company Information
Arbutus Biopharma is a Vancouver biotech company focused on therapies for chronic hepatitis B virus infection. The company’s strategy is built around combination drug development and a three-pronged approach to HBV cure: suppress viral DNA, reduce viral antigens, and boost the host immune response. Its portfolio includes RNAi-based therapeutics such as imdusiran and other complementary antiviral approaches.
Industry Focus and Technologies
Antiviral therapeutics, hepatitis B, RNA interference, virology, combination drug development, and biopharmaceutical R&D.
Location
Vancouver, British Columbia, Canada
Company Size and Stage
Products, Platforms or Focus Areas
HBV therapeutic programs; RNAi therapeutic imdusiran; and combination regimens designed to suppress viral replication, reduce HBsAg, and restore immune response.